6月19日一位股民将德纳维制药(Dynavax Technologies Corp,DVAX)诉至加州北区法院,诉状指控该公司在...查看全文
淡投2011-07-08 14:33
$德纳维制药(DVAX)$ 是一家正处于发展阶段的生物制药公司,旨在研发出预防和治疗传染病的新药。它的明星产品包括HEPLISAV,这是一种正处于第三阶段试用的成人乙肝疫苗,它比市面上其他的许可疫苗所需用的剂量更少,还适用糖尿病人。查看全文
$Dyax(DYAX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-12 AccNo: 0001104659-16-096141 Size: 70 KB 网页链接
$Dyax(DYAX)$ EFFECT - Notice of Effectiveness Filed: 2016-02-10 AccNo: 9999999995-16-003718 Size: 1 KB 网页链接
$Dyax(DYAX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-09 AccNo: 0001623632-16-002292 Size: 103 KB 网页链接
$Dyax(DYAX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-08 AccNo: 0001623632-16-002288 Size: 105 KB 网页链接
$Dyax(DYAX)$ CT ORDER - Confidential treatment order Filed: 2016-02-05 AccNo: 9999999997-16-016575 Size: 10 KB 网页链接
$Dyax(DYAX)$ 15-12G - Securities registration termination [Section 12(g)] Filed: 2016-02-01 AccNo: 0001104659-16-092917 Size: 23 KB 网页链接
$Dyax(DYAX)$ CT ORDER - Confidential treatment order Filed: 2016-02-01 AccNo: 9999999997-16-016468 Size: 10 KB 网页链接
$Dyax(DYAX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-01-26 AccNo: 0000215457-16-002509 Size: 13 KB 网页链接
$Dyax(DYAX)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2016-01-22 AccNo: 0001104659-16-091049 Size: 43 KB 网页链接
$Dyax(DYAX)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2016-01-22 AccNo: 0001104659-16-091048 Size: 43 KB 网页链接